Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 1,283 | 1,173 | 1,240 | 902 | 2,311 |
| Cost of Goods | 817 | 883 | 916 | 881 | 741 |
| Gross Profit | 466 | 289 | 324 | 21 | 1,570 |
| Operating Expenses | 2,475 | 2,086 | 2,029 | 2,646 | 2,087 |
| Operating Income | -2,009 | -1,796 | -1,705 | -2,624 | -516 |
| Other Income | 78 | 73 | 227 | 88 | 180 |
| Pre-tax Income | -1,931 | -1,723 | -1,478 | -2,537 | -337 |
| Income Tax | 7 | 0 | 0 | 0 | 2 |
| Net Income Continuous | -1,938 | -1,723 | -1,478 | -2,537 | -338 |
| Net Income | $-1,938 | $-1,723 | $-1,478 | $-2,537 | $-338 |
| EBITDA(a) | $-1,857 | $-1,645 | $-1,552 | $-2,475 | $-365 |